Ann: Trading Halt, page-124

Hey thrasher she has to go IMO. The ship has been unstable since the FDA rejection.
Since then everything she has touched has turned to dust.
FDA consultants hired with no outcomes for vivagel.
A tantalising 127m deal sat waiting on approval of vivagel.
Delays in DEP trials.
Viraleze distribution agreements.
Poor sales of viraleze.
Not a single distribution agreement in many of the areas where regulatory approval granted.
UK and AUS regulatory fines.
Out if ASX 300.
Not one licence deal for DEP.
No dollars for any partnership agreement with merck, sun or genetech.
And now Astrazeneca pull plug on phase 2 pay day.
JF needs to leave now, start again with a new CEO. I now wonder why so many execs have left the last 18 months. AND no on market purchases by management.
Her 5m shares will be worth about 15c a pop come open after TH.
65% of shares held by top 20, i bet they've had personal calls from management.....They have to hold a webinar to explain this.....then she can turn lights off on way out the door.
its a sell now.